‘Omicron sub-variant linked to Singapore Covid spike gains ground in India: Official
A new Omicron sub-variant of Covid-19, dubbed XBB and responsible for a sharp surge in cases in Singapore, is gaining ground in India, with at...
Continue ReadingAjanta Pharma Awarded “India’s Best Managed Companies” By Deloitte
Ajanta Pharma, a specialty pharmaceutical formulation company, has been awarded as “Best Managed Companies” in India by Deloitte for 2022.The selection process for the award...
Continue ReadingAmneal Pharma starts commercial operations in India
The US-headquartered generic and specialty drug products maker Amneal Pharmaceuticals, Inc said commencing of India commercial operationsand has appointed Shyamakant Giri as Managing Director and...
Continue ReadingMarksans Pharma to acquire Tevapharm’s bulk formulations business
Drug firm Marksans Pharma on other day said it has inked a pact with Tevapharm India to acquire its Goa-based bulk pharmaceutical formulations business.The company...
Continue ReadingSun Pharma Gets CDSCO Panel Nod To Manufacture, Market Progesterone SR Tablet
The drug major Sun Pharma has got green signal from the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) to manufacture...
Continue ReadingDr. Reddy’s Labs partners with IQVIA for improving customer interaction service in India
IQVIA on other day announced that Dr. Reddy’s Laboratories has selected IQVIA Orchestrated Customer Engagement (OCE) platform as its core CRM solution for its entire...
Continue ReadingPfizer Completes Acquisition of Biohaven Pharmaceuticals
Pfizer Inc. announced today the completion of its acquisition of Biohaven Pharmaceutical Holding Company Ltd., the maker of NURTEC® ODT (rimegepant), an innovative migraine therapy...
Continue ReadingFinal approval from US FDA for Zydus’ mirabegron
Indian generics major Zydus Lifesciences (NYSE: ZYDUSLIFE) has received final approval from the US Food and Drug Administration (FDA) to market mirabegron extended-release tablets USP...
Continue ReadingNEW GLOW Torrent Pharma to acquire Curatio Healthcare for ₹2,000 crore
Torrent Pharmaceuticals Limited on Otherday announced acquisition of the Chennai-based leading dermatology player Curatio Healthcare (I) Private Limited for ₹2,000 crore. Torrent Pharma has entered...
Continue Reading